Beam Therapeutics 

BEAM NASDAQ
Overview Stats Financials News

Price & Volume

Stats

See more
52W Range $16.95-$49.50
Market Cap $1.9B
Shares Short 14M

Financials

See more
Revenue (12 Mos) $360.9M
Revenue Growth (YoY) -69.4%
Gross Profit (12 Mos) -$250.6M
Diluted EPS -$1.60

About

CEO Mr. John M. Evans M.B.A.
CFO Ms. Terry-Ann Burrell M.B.A.
Address 238 Main Street, Cambridge, MA, United States, 02142-1016
Sector Healthcare
Industry Biotechnology
Full-Time Employees 346